Sara Cerenius
Doktorand vid Institutionen för medicinsk cellbiologi; Forskargrupp Peter Bergsten
- E-post:
- sara.cerenius@mcb.uu.se
- Besöksadress:
- BMC
Husargatan 3
751 23 Uppsala - Postadress:
- Box 571
751 23 UPPSALA
Publikationer
Senaste publikationer
-
Ingår i Cardiovascular Diabetology, 2025
- DOI för Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS
- Ladda ner fulltext (pdf) av Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS
-
Ingår i Cardiovascular Diabetology, 2025
- DOI för Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS
- Ladda ner fulltext (pdf) av Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS
-
Ingår i Frontiers in Endocrinology, 2023
- DOI för Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control
- Ladda ner fulltext (pdf) av Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control
-
Ingår i Annals of Nutrition and Metabolism, s. 522-527, 2023
-
Ingår i Metabolites, 2023
- DOI för Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
- Ladda ner fulltext (pdf) av Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
Alla publikationer
Artiklar i tidskrift
-
Ingår i Cardiovascular Diabetology, 2025
- DOI för Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS
- Ladda ner fulltext (pdf) av Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS
-
Ingår i Cardiovascular Diabetology, 2025
- DOI för Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS
- Ladda ner fulltext (pdf) av Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS
-
Ingår i Frontiers in Endocrinology, 2023
- DOI för Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control
- Ladda ner fulltext (pdf) av Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control
-
Ingår i Annals of Nutrition and Metabolism, s. 522-527, 2023
-
Ingår i Metabolites, 2023
- DOI för Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
- Ladda ner fulltext (pdf) av Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
-
Metformin Can Attenuate Beta-Cell Hypersecretion-Implications for Treatment of Children with Obesity
Ingår i Metabolites, 2023
- DOI för Metformin Can Attenuate Beta-Cell Hypersecretion-Implications for Treatment of Children with Obesity
- Ladda ner fulltext (pdf) av Metformin Can Attenuate Beta-Cell Hypersecretion-Implications for Treatment of Children with Obesity
-
Ingår i Pediatric Obesity, 2022
- DOI för High levels of FSH before puberty are associated with increased risk of metabolic syndrome during pubertal transition
- Ladda ner fulltext (pdf) av High levels of FSH before puberty are associated with increased risk of metabolic syndrome during pubertal transition
-